| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-07-04 14:38 Tx date 2025-07-02 |
$INNO
InnoCan Pharma Corporation |
Lintern, Joshua Aaron
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+350,000 vol |
350,000 | |
| Filed 2025-03-20 18:26 Tx date 2025-03-18 |
$INNO
InnoCan Pharma Corporation |
Lintern, Joshua Aaron
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$9,100
+43,334 vol $0.21 each |
247,000 | |
| Filed 2025-03-20 18:25 Tx date 2025-03-18 |
$INNO
InnoCan Pharma Corporation |
Lintern, Joshua Aaron
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Restricted Share Units
38 - Redemption, retraction, cancellation, repurchase
|
-23,334 vol |
0 | |
| Filed 2025-03-20 18:25 Tx date 2025-03-18 |
$INNO
InnoCan Pharma Corporation |
Lintern, Joshua Aaron
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-43,334 vol |
23,334 | |
| Filed 2024-09-23 14:01 Tx date 2024-09-20 |
$INNO
InnoCan Pharma Corporation |
Lintern, Joshua Aaron
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$10,399
+43,333 vol $0.24 each |
203,666 | |
| Filed 2024-09-23 14:01 Tx date 2024-09-20 |
$INNO
InnoCan Pharma Corporation |
Lintern, Joshua Aaron
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Restricted Share Units
38 - Redemption, retraction, cancellation, repurchase
|
-23,333 vol |
66,668 | |
| Filed 2024-09-23 14:00 Tx date 2024-09-20 |
$INNO
InnoCan Pharma Corporation |
Lintern, Joshua Aaron
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-43,333 vol |
90,001 | |
| Filed 2024-09-23 09:57 Tx date 2024-09-16 |
$INNO
InnoCan Pharma Corporation |
Lintern, Joshua Aaron
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Restricted Share Units
38 - Redemption, retraction, cancellation, repurchase
|
-23,333 vol |
||
| Filed 2024-09-23 09:57 Tx date 2024-09-16 |
$INNO
InnoCan Pharma Corporation |
Lintern, Joshua Aaron
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-43,333 vol |
||
| Filed 2024-09-23 09:57 Tx date 2024-09-16 |
$INNO
InnoCan Pharma Corporation |
Lintern, Joshua Aaron
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$10,399
+43,333 vol $0.24 each |
||
| Filed 2024-09-20 20:14 Tx date 2024-09-16 |
$INNO
InnoCan Pharma Corporation |
Lintern, Joshua Aaron
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$10,399
+43,333 vol $0.24 each |
||
| Filed 2024-09-20 20:14 Tx date 2024-09-16 |
$INNO
InnoCan Pharma Corporation |
Lintern, Joshua Aaron
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Restricted Share Units
38 - Redemption, retraction, cancellation, repurchase
|
-23,333 vol |
||
| Filed 2024-09-20 20:13 Tx date 2024-09-16 |
$INNO
InnoCan Pharma Corporation |
Lintern, Joshua Aaron
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-43,333 vol |
||
| Filed 2024-09-20 20:14 Tx date 2024-09-16 |
$INNO
InnoCan Pharma Corporation |
Lintern, Joshua Aaron
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$10,399
+43,333 vol $0.24 each |
203,666 | |
| Filed 2024-09-20 20:14 Tx date 2024-09-16 |
$INNO
InnoCan Pharma Corporation |
Lintern, Joshua Aaron
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Restricted Share Units
38 - Redemption, retraction, cancellation, repurchase
|
-23,333 vol |
66,668 | |
| Filed 2024-09-20 20:13 Tx date 2024-09-16 |
$INNO
InnoCan Pharma Corporation |
Lintern, Joshua Aaron
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-43,333 vol |
90,001 | |
| Filed 2024-03-28 10:41 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Lintern, Joshua Aaron
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+43,333 vol |
160,333 | |
| Filed 2024-03-28 10:40 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Lintern, Joshua Aaron
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+117,000 vol |
117,000 | |
| Filed 2024-03-28 10:40 Tx date 2019-09-25 |
$INNO
InnoCan Pharma Corporation |
Lintern, Joshua Aaron
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-03-28 10:40 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Lintern, Joshua Aaron
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Restricted Share Units
38 - Redemption, retraction, cancellation, repurchase
|
-23,333 vol |
133,334 |